SOBRsafe Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds

Rhea-AI Summary

SOBRsafe (Nasdaq:SOBR) closed the previously announced cash exercise of certain outstanding warrants originally issued in December 2025 to purchase up to 2,360,648 shares of common stock at $1.30 per share, generating approximately $3.1 million in gross proceeds before fees and expenses.

In connection with the immediate exercise, SOBRsafe issued new unregistered Series E warrants to purchase up to 2,580,648 shares and Series F warrants to purchase up to 2,140,648 shares, each with a $1.30 exercise price and different expiry terms tied to the effective date of a future resale registration statement. According to SOBRsafe, net proceeds will be used for working capital and general corporate purposes, supporting its balance sheet and proposed merger.

Positive

• $3.1 million gross proceeds from warrant exercises
• Immediate cash from exercise of 2,360,648 warrants at $1.30
• Additional capital earmarked for working capital and general corporate purposes

Negative

• New Series E warrants for up to 2,580,648 shares create future dilution risk
• New Series F warrants for up to 2,140,648 shares add further potential dilution

Market reaction after warrant exercise financing: SOBR -23.07% in the Jul 17 session

-23.07%

17 alerts

-23.07% Session close to close

-23.2% Trough in 7 hr 2 min

$5.95M Market Cap

0.2x Rel. Volume

In the Jul 17 session, SOBR declined 23.07%, reflecting a significant negative market reaction. Argus tracked a trough of -23.2% from its starting point during tracking. Our momentum scanner triggered 17 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock dropped -23.1% in the session following this news. The last offering-tagged headline on Ju...

Analysis

The stock dropped -23.1% in the session following this news. The last offering-tagged headline on Jul 15, 2026 coincided with a -51.69% move, so another steep decline would fit that financing pattern. With short positioning flagged as low, pressure would more likely reflect dilution and merger execution risk than a squeeze dynamic.

Key Figures

Underlying shares: 2,360,648 shares Exercise price: $1.30 per share Series E warrant shares: 2,580,648 shares +4 more

7 metrics

Underlying shares 2,360,648 shares Warrants exercised, originally issued December 2025

Exercise price $1.30 per share Exercised warrants and new Series E and F warrants

Series E warrant shares 2,580,648 shares New unregistered Series E warrants issued in connection with exercise

Series F warrant shares 2,140,648 shares New unregistered Series F warrants issued in connection with exercise

Series E term 5 years Expiry after effective date of Resale Registration Statement

Series F term 24 months Expiry after effective date of Resale Registration Statement

Gross proceeds $3.1 million Aggregate gross proceeds to the company before fees

Previous Offering Reports

1 past event · Latest: Jul 15 (Negative)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 15	Warrant exercise financing	Negative	-51.7%	Immediate cash exercise of warrants and issuance of new Series E and F warrants.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The only prior offering-tagged event saw a -51.69% drop following warrant exercise financing.

Key Terms

warrants, form s-1, private placement, resale registration statement, +1 more

5 terms

warrants financial

"exercise of certain outstanding warrants to purchase up to an aggregate of 2,360,648 shares"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

View in glossary

form s-1 regulatory

"registered pursuant to an effective registration statement on Form S-1 (No. 333-292709)"

A Form S-1 is the registration filing a company submits to the U.S. Securities and Exchange Commission when it plans to offer stock to the public, most commonly for an initial public offering. Think of it as the company’s full disclosure packet or blueprint: it contains audited financials, business description, management background, risk factors and details of the offering, giving investors the information needed to judge the company’s financial health and potential risks before buying shares.

private placement financial

"The new warrants described above were offered in a private placement pursuant to an applicable exemption"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

resale registration statement regulatory

"will expire five years after the effective date of the Resale Registration Statement"

A resale registration statement is a document filed with regulators that allows existing shareholders to sell their shares to the public. It provides the necessary legal approval and information for these shares to be resold on the market, helping to increase the availability of shares for trading. For investors, it signals that shares held by current owners can be offered for sale, potentially affecting share prices and market liquidity.

placement agent financial

"H.C. Wainwright & Co. acted as the exclusive placement agent for the offering"

A placement agent is a professional or firm that helps organizations raise money from investors, such as individuals, institutions, or funds. They act like matchmakers, connecting those seeking investments with the right investors and guiding the process to ensure successful funding. For investors, they can provide access to exclusive opportunities and help navigate complex fundraising efforts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Company Improves Balance Sheet With Additional Capital to Support Proposed Merger

DENVER, CO / ACCESS Newswire / July 17, 2026 / SOBR Safe, Inc. (Nasdaq:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, today announced the closing of its previously announced exercise of certain outstanding warrants to purchase up to an aggregate of 2,360,648 shares originally issued in December 2025, having an exercise price of $1.30 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-292709).

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

In consideration for the immediate exercise of the warrants for cash, the Company issued new unregistered Series E warrants to purchase up to 2,580,648 shares of common stock and new unregistered Series F warrants to purchase up to 2,140,648 shares of common stock. The Series E new warrants have an exercise price of $1.30 per share, are exercisable immediately and will expire five years after the effective date of the Resale Registration Statement (as defined below). The Series F new warrants have an exercise price of $1.30 per share, are exercisable immediately and will expire twenty-four months after the effective date of the Resale Registration Statement (as defined below).

The aggregate gross proceeds to the Company from the offering were approximately $3.1 million, before deducting placement agent fees and other offering expenses. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the "Act") and, along with the shares of common stock issuable upon their exercise, have not been registered under the Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission ("SEC") or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the "Resale Registration Statement").

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About SOBRsafe^™

Through next-generation alcohol detection technology, we enable trust and empower recovery ... with a human touch. SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. To learn more, visit www.sobrsafe.com.

Safe Harbor Statement

Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding the intended use of net proceeds from the offering, and the Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this news release. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "will," "would" or other similar expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward-looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company's filings with the SEC which can be found on the SEC's website at www.sec.gov.

Company Contact:

IR@sobrsafe.com

Investor Relations Contact:

Christopher Whitaker
Chief Financial Officer
1.844.SOBRsafe (762.7723)
IR@sobrsafe.com

SOURCE: SOBR Safe, Inc.

View the original press release on ACCESS Newswire

FAQ

What did SOBRsafe (SOBR) announce on July 17, 2026 regarding warrant exercises?

SOBRsafe announced the closing of warrant exercises generating about $3.1 million in gross proceeds. According to SOBRsafe, holders exercised 2,360,648 existing warrants at $1.30 per share, strengthening the company’s balance sheet ahead of its proposed merger and funding working capital needs.

How much capital did SOBRsafe (SOBR) raise from its July 2026 warrant exercise?

SOBRsafe raised approximately $3.1 million in gross proceeds from warrant exercises. According to SOBRsafe, the cash came from the immediate exercise of certain December 2025 warrants at $1.30 per share and will be used for working capital and general corporate purposes.

What are the terms of SOBRsafe’s new Series E and Series F warrants (SOBR)?

The new Series E and Series F warrants each have a $1.30 exercise price and are exercisable immediately. According to SOBRsafe, Series E covers up to 2,580,648 shares for five years, while Series F covers up to 2,140,648 shares for twenty-four months after the resale registration becomes effective.

Will SOBRsafe (SOBR) shares from the new warrants be registered for resale?

The new warrants and underlying shares are initially unregistered, issued via private placement. According to SOBRsafe, the company has agreed to file a resale registration statement with the SEC to cover common shares issuable upon exercise of the new Series E and Series F warrants.

How might the SOBRsafe (SOBR) warrant transaction affect future share dilution?

The transaction introduces potential dilution from new Series E and F warrants covering over 4.7 million shares. According to SOBRsafe, these unregistered warrants are exercisable immediately and have terms of five years and twenty-four months, which could expand the share count if exercised.

Who acted as placement agent for SOBRsafe’s July 2026 warrant exercise (SOBR)?

H.C. Wainwright & Co. served as the exclusive placement agent for SOBRsafe’s warrant exercise transaction. According to SOBRsafe, the agent’s fees and other offering expenses will be deducted from the approximately $3.1 million in gross proceeds to determine the net capital available to the company.